Wellbiotec Co. Ltd.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more
Wellbiotec Co. Ltd. (010600) - Total Liabilities
Latest total liabilities as of December 2024: ₩11.76 Billion KRW
Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) has total liabilities worth ₩11.76 Billion KRW as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Wellbiotec Co. Ltd. - Total Liabilities Trend (2002–2024)
This chart illustrates how Wellbiotec Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Wellbiotec Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Wellbiotec Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Franklin Wireless Corp
NASDAQ:FKWL
|
USA | $14.93 Million |
|
Golden Eagle Energy Tbk
JK:SMMT
|
Indonesia | Rp917.15 Billion |
|
SMG European Recovery SPAC SE
XETRA:RCVR
|
Germany | €48.45 Million |
|
Evermore Chemical Industry Co Ltd
TW:1735
|
Taiwan | NT$1.65 Billion |
|
Bo Lak
KO:002760
|
Korea | ₩10.77 Billion |
|
Romsdal Sparebank
OL:ROMSB
|
Norway | Nkr7.12 Billion |
|
Acrinova AB Series B
ST:ACRI-B
|
Sweden | Skr472.42 Million |
|
Caprice Resources Limited
F:C3F
|
Germany | €375.09K |
Liability Composition Analysis (2002–2024)
This chart breaks down Wellbiotec Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Wellbiotec Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Wellbiotec Co. Ltd. (2002–2024)
The table below shows the annual total liabilities of Wellbiotec Co. Ltd. from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩11.76 Billion | -48.90% |
| 2023-12-31 | ₩23.02 Billion | +2.72% |
| 2022-12-31 | ₩22.41 Billion | -78.35% |
| 2021-12-31 | ₩103.52 Billion | +101.28% |
| 2020-12-31 | ₩51.43 Billion | +16.39% |
| 2019-12-31 | ₩44.19 Billion | +27.14% |
| 2018-12-31 | ₩34.76 Billion | -42.22% |
| 2017-12-31 | ₩60.16 Billion | +131.31% |
| 2016-12-31 | ₩26.01 Billion | +15.50% |
| 2015-12-31 | ₩22.52 Billion | -13.84% |
| 2014-12-31 | ₩26.13 Billion | +27.23% |
| 2013-12-31 | ₩20.54 Billion | -20.31% |
| 2012-12-31 | ₩25.77 Billion | -18.13% |
| 2011-12-31 | ₩31.48 Billion | +39.31% |
| 2010-12-31 | ₩22.60 Billion | -18.94% |
| 2009-12-31 | ₩27.88 Billion | -46.94% |
| 2008-12-31 | ₩52.54 Billion | -18.07% |
| 2007-12-31 | ₩64.13 Billion | -38.63% |
| 2006-12-31 | ₩104.50 Billion | -7.72% |
| 2005-12-31 | ₩113.23 Billion | +21.32% |
| 2004-12-31 | ₩93.33 Billion | +8.66% |
| 2003-12-31 | ₩85.90 Billion | +48.25% |
| 2002-12-31 | ₩57.94 Billion | -- |